{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Erewash&max-date=2018-04-16&answer.answeringMemberPrinted=Jane+Ellison&max-answer.dateOfAnswer=2017-02-02", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberConstituency=Erewash&max-date=2018-04-16&answer.answeringMemberPrinted=Jane+Ellison&max-answer.dateOfAnswer=2017-02-02", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Erewash&max-date=2018-04-16&_metadata=all&answer.answeringMemberPrinted=Jane+Ellison&max-answer.dateOfAnswer=2017-02-02", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&tablingMemberConstituency=Erewash&max-date=2018-04-16&answer.answeringMemberPrinted=Jane+Ellison&max-answer.dateOfAnswer=2017-02-02", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Erewash&max-date=2018-04-16&answer.answeringMemberPrinted=Jane+Ellison&max-answer.dateOfAnswer=2017-02-02", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Erewash&max-date=2018-04-16&answer.answeringMemberPrinted=Jane+Ellison&max-answer.dateOfAnswer=2017-02-02", "items" : [{"_about" : "http://data.parliament.uk/resources/670088", "AnsweringBody" : [{"_value" : "HM Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/670088/answer", "answerText" : {"_value" : "

The Money Purchase Annual Allowance applies to anyone who has accessed their pension savings flexibly and makes further money purchase savings. It applies at the level in force at the time of making those subsequent savings.<\/p>

The Government has proposed a reduction in the allowance to £4,000 from 6 April 2017 and launched a consultation on the detail surrounding this, which ends on 15 February and is available at:<\/p>

https://www.gov.uk/government/consultations/reducing-the-money-purchase-annual-allowance<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2017-01-17", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-01-17T17:17:00.73Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "CaTreasury"} , "date" : {"_value" : "2017-01-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pensions"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask Mr Chancellor of the Exchequer, whether the reduction to £4,000 in the Money Purchase Annual Allowance referred to in paragraph 4.20 of the Autumn Statement 2016, Cm 9362, will apply to people who had already accessed their savings flexibly.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4447", "label" : {"_value" : "Biography information for Maggie Throup"} } , "tablingMemberConstituency" : {"_value" : "Erewash"} , "tablingMemberPrinted" : [{"_value" : "Maggie Throup"} ], "uin" : "59110"} , {"_about" : "http://data.parliament.uk/resources/513011", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/513011/answer", "answerText" : {"_value" : "

NHS England has placed its position on the commissioning of pre-exposure prophylaxis (PrEP) under review. This review of the commissioning process will be undertaken by the Specialised Services Committee of NHS England in late May 2016. Depending on the outcome of that decision, a further decision taking account of the clinical evidence for PrEP, the evidence and demand for other new treatments not currently commissioned and NHS England's available funding and priorities is currently planned for June 2016.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2016-04-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-04-21T14:19:15.423Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-04-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "HIV Infection: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what the evidential basis is for NHS England's decision not to fund the pre-exposure drug prophyaxis for HIV for the at-risk population.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4447", "label" : {"_value" : "Biography information for Maggie Throup"} } , "tablingMemberConstituency" : {"_value" : "Erewash"} , "tablingMemberPrinted" : [{"_value" : "Maggie Throup"} ], "uin" : "34125"} , {"_about" : "http://data.parliament.uk/resources/513019", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/513019/answer", "answerText" : {"_value" : "

The planning of the process to select test sites, including timing and criteria for selection, will continue alongside NHS England\u2019s review of its position on the commissioning of pre-exposure prophyaxis (PrEP).<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2016-04-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-04-22T13:06:13.567Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-04-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "HIV Infection: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, which areas have been chosen as test sites for the pre-exposure drug prophyaxis (PrEP); what selection criteria have been used to identify those test sites; and what measures his Department plans to use to assess the effectiveness of PrEP in the test sites over the next two years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4447", "label" : {"_value" : "Biography information for Maggie Throup"} } , "tablingMemberConstituency" : {"_value" : "Erewash"} , "tablingMemberPrinted" : [{"_value" : "Maggie Throup"} ], "uin" : "34127"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }